Whole Metagenome Sequencing Reveals Links Between Mosquito
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Pluralibacter Gergoviae Als Spender- Oder Empfängerorganismus Gemäß § 5 Absatz 1 Gentsv
Az. 45241.0205 Juni 2020 Empfehlung der ZKBS zur Risikobewertung von Pluralibacter gergoviae als Spender- oder Empfängerorganismus gemäß § 5 Absatz 1 GenTSV Allgemeines Pluralibacter gergoviae (früher: Enterobacter gergoviae [1]) ist ein Gram-negatives, fakultativ anaerobes, peritrich begeißeltes, stäbchenförmiges Bakterium aus der Familie der Enterobacteriaceae, das zuerst 1980 beschrieben wurde [2]. Es ist weltweit verbreitet und wurde aus klinischen Proben (Blut, Urin, Sputum, Stuhl, Hautabstriche, Ohrendrainage, nicht näher beschriebene Wunden, Abszesse, Lunge, Niere) sowie aus dem Darm eines Roten Baumwollkapselwurms, Wasserproben und Kosmetikprodukten isoliert [2–7]. Das Überleben in Kosmetikprodukten wird dadurch ermöglicht, dass P. gergoviae eine hohe Toleranz gegen Konservierungsmittel wie Benzoesäure und Parabenen aufweist [8]. Aufgrund dieser Toleranz ist P. gergoviae in der Vergangenheit mehrfach als mikrobielle Verunreinigung in Kosmetikprodukten aufgetreten, die daraufhin zurückgerufen werden mussten [9]. Im klinischen Kontext tritt P. gergoviae vergleichsweise selten als Krankheitserreger auf. Das Bakterium löst vor allem bei Immunkompromittierten Infektionen aus, die tödlich verlaufen können. Es verursachte Harnwegsinfektionen oder Infektionen der Operationswunde bei Empfängern von Nierentransplantaten [10], mehrere Sepsisfälle auf einer Neugeborenenstation, von denen die Mehrzahl Frühgeborene betrafen [3], und führte zu einem Septischen Schock bei einem Leukämie-Patienten [11]. Bei Immunkompetenten wurden eine Sepsis -
Data-Driven Identification of Potential Zika Virus Vectors Michelle V Evans1,2*, Tad a Dallas1,3, Barbara a Han4, Courtney C Murdock1,2,5,6,7,8, John M Drake1,2,8
RESEARCH ARTICLE Data-driven identification of potential Zika virus vectors Michelle V Evans1,2*, Tad A Dallas1,3, Barbara A Han4, Courtney C Murdock1,2,5,6,7,8, John M Drake1,2,8 1Odum School of Ecology, University of Georgia, Athens, United States; 2Center for the Ecology of Infectious Diseases, University of Georgia, Athens, United States; 3Department of Environmental Science and Policy, University of California-Davis, Davis, United States; 4Cary Institute of Ecosystem Studies, Millbrook, United States; 5Department of Infectious Disease, University of Georgia, Athens, United States; 6Center for Tropical Emerging Global Diseases, University of Georgia, Athens, United States; 7Center for Vaccines and Immunology, University of Georgia, Athens, United States; 8River Basin Center, University of Georgia, Athens, United States Abstract Zika is an emerging virus whose rapid spread is of great public health concern. Knowledge about transmission remains incomplete, especially concerning potential transmission in geographic areas in which it has not yet been introduced. To identify unknown vectors of Zika, we developed a data-driven model linking vector species and the Zika virus via vector-virus trait combinations that confer a propensity toward associations in an ecological network connecting flaviviruses and their mosquito vectors. Our model predicts that thirty-five species may be able to transmit the virus, seven of which are found in the continental United States, including Culex quinquefasciatus and Cx. pipiens. We suggest that empirical studies prioritize these species to confirm predictions of vector competence, enabling the correct identification of populations at risk for transmission within the United States. *For correspondence: mvevans@ DOI: 10.7554/eLife.22053.001 uga.edu Competing interests: The authors declare that no competing interests exist. -
CATALOGO GENERALE - Listino Prezzi 2020 2021 Chromart CATALOGOTERRENI GENERALE Listinocromogeni Prezzi 2021 - 2022 Per La Microbiologia Industriale
Microbiologia Microbiologia Microbiologia Microbiologia Microbiologia Microbiologia CATALOGO GENERALE - Listino Prezzi 2020 2021 CATALOGO ChromArt CATALOGOTERRENI GENERALE ListinoCROMOGENI Prezzi 2021 - 2022 Per la Microbiologia Industriale Microbiologia Clinica e Industriale Ph: A. Geraci Microbiologia Clinica e Industriale Terreni cromogeni Rev. 02/2021 per l’isolamento e l’identificazione dei principali patogeni ed indicatori fecali negli alimenti, mangimi ed acque. Biolife Biolife ItalianaBiolife srl - VItalianaiale Monza srl - 272Viale 20128 Monza Milano272 20128 - Tel. 02Milano 25209.1 - Tel. 02- www 25209.1.biolifeitaliana.i - www.biolifeitaliana.it t Biolife Italiana srl - Viale Monza 272 20128 Milano - Tel. 02 25209.1 - www.biolifeitaliana.it t .biolifeitaliana.i www - 25209.1 02 l. Te - Milano 20128 272 Monza iale V - l sr Italiana Biolife CONDIZIONI GENERALI DI VENDITA PREZZI I prezzi segnati nei nostri listini si intendono Iva esclusa e sono comprensivi di imballo normale e spedizione con vettori con noi convenzionati. Gli imballi speciali e/o refrigerati saranno addebitati al costo. Le spedizioni con vettori scelti dal cliente saranno a carico di quest’ultimo. L’IVA (Imposta sul Valore Aggiunto) è sempre a carico del Committente nella misura di legge. ORDINI Gli ordini devono essere formulati per iscritto e verranno evasi rispettando le unità di confezioni indicate nel listino. Per evitare errori raccomandiamo di indicare sempre negli ordini il numero di codice e la denominazione di ciascun articolo nonché la quantità richiesta. È nostro diritto accettare, annullare e procrastinare in tutto o in parte ordini a seguito di sopravvenute impossibilità da parte nostra, dei nostri fornitori e dei vettori. Tali cause ci sollevano da ogni obbligo precedentemente assunto con l’accettazione dell’ordine. -
2021 ECCMID | 00656 in Vitro Activities of Ceftazidime-Avibactam and Comparator Agents Against Enterobacterales
IHMA In Vitro Activities of Ceftazidime-avibactam and Comparator Agents against Enterobacterales and 2122 Palmer Drive 00656 Schaumburg, IL 60173 USA Pseudomonas aeruginosa from Israel Collected Through the ATLAS Global Surveillance Program 2013-2019 www.ihma.com M. Hackel1, M. Wise1, G. Stone2, D. Sahm1 1IHMA, Inc., Schaumburg IL, USA, 2Pfizer Inc., Groton, CT USA Introduction Results Results Summary Avibactam (AVI) is a non-β- Table 1 Distribution of 2,956 Enterobacterales from Israel by species Table 2. In vitro activity of ceftazidime-avibactam and comparators agents Figure 2. Ceftazidime and ceftazidime-avibactam MIC distribution against 29 . Ceftazidime-avibactam exhibited a potent lactam, β-lactamase inhibitor against Enterobacterales and P. aeruginosa from Israel, 2013-2019 non-MBL carbapenem-nonsusceptible (CRE) Enterobacterales from Israel, antimicrobial activity higher than all Organism N % of Total mg/L that can restore the activity of Organism Group (N) %S 2013-2019 comparator agents against all Citrobacter amalonaticus 2 0.1% MIC90 MIC50 Range ceftazidime (CAZ) against Enterobacterales (2956) 20 Enterobacterales from Israel (MIC90, 0.5 Citrobacter braakii 5 0.2% Ceftazidime-avibactam 99.8 0.5 0.12 ≤0.015 - > 128 Ceftazidime Ceftazidime-avibactam organisms that possess Class 18 mg/L; 99.8% susceptible). Citrobacter freundii 96 3.2% Ceftazidime 70.1 64 0.25 ≤0.015 - > 128 A, C, and some Class D β- Cefepime 71.8 > 16 ≤0.12 ≤0.12 - > 16 16 . Susceptibility to ceftazidime-avibactam lactmase enzymes. This study Citrobacter gillenii 1 <0.1% Meropenem 98.8 0.12 ≤0.06 ≤0.06 - > 8 increased to 100% for the Enterobacterales Amikacin 95.4 8 2 ≤0.25 - > 32 14 examined the in vitro activity Citrobacter koseri 123 4.2% when MBL-positive isolates were removed Colistin (n=2544)* 82.2 > 8 0.5 ≤0.06 - > 8 12 of CAZ-AVI and comparators Citrobacter murliniae 1 <0.1% Piperacillin-tazobactam 80.4 32 2 ≤0.12 - > 64 from analysis. -
Hickman Catheter-Related Bacteremia with Kluyvera
Jpn. J. Infect. Dis., 61, 229-230, 2008 Short Communication Hickman Catheter-Related Bacteremia with Kluyvera cryocrescens: a Case Report Demet Toprak, Ahmet Soysal, Ozden Turel, Tuba Dal1, Özlem Özkan1, Guner Soyletir1 and Mustafa Bakir* Department of Pediatrics, Section of Pediatric Infectious Diseases and 1Department of Microbiology, Marmara University School of Medicine, Istanbul, Turkey (Received September 10, 2007. Accepted March 19, 2008) SUMMARY: This report describes a 2-year-old child with neuroectodermal tumor presenting with febrile neu- tropenia. Blood cultures drawn from the peripheral vein and Hickman catheter revealed Kluyvera cryocrescens growth. The Hickman catheter was removed and the patient was successfully treated with cefepime and amikacin. Isolation of Kluyvera spp. from clinical specimens is rare. This saprophyte microorganism may cause serious central venous catheter infections, especially in immunosuppressed patients. Clinicians should be aware of its virulence and resistance to many antibiotics. Central venous catheters (CVCs) are frequently used in confirmed by VITEK AMS (VITEK Systems, Hazelwood, Mo., patients with hematologic and oncologic disorders. Along with USA) and by API (Analytab Inc., Plainview, N.Y., USA). Anti- their increased use, short- and long-term complications of microbial susceptibility was assessed by the disc diffusion CVCs are more often being reported. The incidence of CVC method. K. cryocrescens was sensitive for cefotaxime, cefepime, infections correlates with duration of catheter usage, immuno- carbapenems, gentamycine, amikacin and ciprofloxacin. logic status of the patient, type of catheter utilized and mainte- Intravenous cefepime and amikacin were continued and the nance techniques employed. A definition of CVC infection CVC was removed. His echocardiogram was normal and has been difficult to establish because of problems differen- a repeat peripheral blood culture was sterile 48 h after the tiating contaminant from pathogen microorganisms. -
The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease Jonathan Z
REVIEW pubs.acs.org/CR The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease Jonathan Z. Long* and Benjamin F. Cravatt* The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States CONTENTS 2.4. Other Phospholipases 6034 1. Introduction 6023 2.4.1. LIPG (Endothelial Lipase) 6034 2. Small-Molecule Hydrolases 6023 2.4.2. PLA1A (Phosphatidylserine-Specific 2.1. Intracellular Neutral Lipases 6023 PLA1) 6035 2.1.1. LIPE (Hormone-Sensitive Lipase) 6024 2.4.3. LIPH and LIPI (Phosphatidic Acid-Specific 2.1.2. PNPLA2 (Adipose Triglyceride Lipase) 6024 PLA1R and β) 6035 2.1.3. MGLL (Monoacylglycerol Lipase) 6025 2.4.4. PLB1 (Phospholipase B) 6035 2.1.4. DAGLA and DAGLB (Diacylglycerol Lipase 2.4.5. DDHD1 and DDHD2 (DDHD Domain R and β) 6026 Containing 1 and 2) 6035 2.1.5. CES3 (Carboxylesterase 3) 6026 2.4.6. ABHD4 (Alpha/Beta Hydrolase Domain 2.1.6. AADACL1 (Arylacetamide Deacetylase-like 1) 6026 Containing 4) 6036 2.1.7. ABHD6 (Alpha/Beta Hydrolase Domain 2.5. Small-Molecule Amidases 6036 Containing 6) 6027 2.5.1. FAAH and FAAH2 (Fatty Acid Amide 2.1.8. ABHD12 (Alpha/Beta Hydrolase Domain Hydrolase and FAAH2) 6036 Containing 12) 6027 2.5.2. AFMID (Arylformamidase) 6037 2.2. Extracellular Neutral Lipases 6027 2.6. Acyl-CoA Hydrolases 6037 2.2.1. PNLIP (Pancreatic Lipase) 6028 2.6.1. FASN (Fatty Acid Synthase) 6037 2.2.2. PNLIPRP1 and PNLIPR2 (Pancreatic 2.6.2. -
Isolation and Characterization of the Prolyl Aminopeptidase Gene (Pap) from Aeromonas Sobria: Comparison with the Bacillus Coagulans Enzyme1
J. Biochem. 116, 818-825 (1994) Isolation and Characterization of the Prolyl Aminopeptidase Gene (pap) from Aeromonas sobria: Comparison with the Bacillus coagulans Enzyme1 Ana Kitazono,* Atsuko Kitano,* Daisuke Tsuru,•õ and Tadashi Yoshimoto*,2 *School of Pharmaceutical Sciences , Nagasaki University, 1-14 Bunkyo-machi, Nagasaki, Nagasaki 852; and •õ Department of Applied Microbiology, Kumamoto Institute of Technology, 4-22-1 Ikeda, Kumamoto, Kumamoto 860 Received for publication, May 16, 1994 The Aeromonas sobria pap gene encoding prolyl aminopeptidase (PAP) was cloned. It consists of 425 codons and encodes a homotetrameric enzyme of 205kDa. The purified enzyme showed an almost absolute specificity for amino-terminal proline. Proline and hydroxyproline residues from many peptide and amide substrates could be easily removed, while no activity was detected for substrates having other amino terminals. The enzyme was very similar to that from Bacillus coagulans in many aspects, such as the strong inhibition caused by PCMB and the weak or no inhibition caused by DFP and chelators, respectively. However, these enzymes show only 15% identity in their amino acid sequences. Differences were also observed in their molecular weight, stability and activity toward some peptide substrates. When aligning the deduced amino acid sequence with known sequences from other microorganisms, conserved sequences were found at the amino-terminal region; the significance of these conserved regions is discussed. Based on the results of this work, and on the studies available to date, the occurrence of at least two types of PAPs is postulated. One group would be formed by the Bacillus, Neisseria, and Lactobacillus enzymes, and the other by enzymes such as the Aeromonas PAP. -
Prevalence of Antibiotic-Resistant, Toxic Metal-Tolerant and Biofilm- Forming Bacteria in Hospital Surroundings
Vol: 35(3), Article ID: e2020018, 19 pages https://doi.org/10.5620/eaht.2020018 eISSN: 2671-9525 1 Original Article 2 Prevalence of antibiotic-resistant, toxic metal-tolerant and biofilm- 3 forming bacteria in hospital surroundings 4 Soumitra Nath1,2,3,* , Ahana Sinha1, Y. Suchitra Singha1, Ankita Dey1, Nilakshi Bhattacharjee1 and Bibhas Deb1,2,3 5 6 1 Department of Biotechnology, Gurucharan College, Silchar, Assam, India 7 2 Bioinformatics Centre, Gurucharan College, Silchar, Assam, India 8 3 Institutional Biotech Hub, Gurucharan College, Silchar, Assam, India 9 *Correspondence: [email protected] 10 11 Received: April 19, 2020 Accepted: August 31, 2020 Abstract The emergence and rapid spread of antibiotic-resistant bacteria due to unethical and non-scientific disposal of hospital wastes and clinical by-products caused an alarming environmental concern and associated public health risks. The present study aims to assess the co-selection of antibiotic resistance and heavy metal tolerance by bacteria isolated from hospital effluents. These isolates were also tested for hemolytic activity, pH-tolerance, thermal inactivation, auto- aggregation, cell-surface hydrophobicity and interaction with other bacteria. The study reports the prevalence of antibiotic-resistant and heavy metal tolerant bacteria in clinical effluents and water samples. Most of these isolates were resistant to vancomycin, clindamycin, ampicillin, rifampicin, penicillin-G, methicillin and cefdinir, and evidenced the production of extended-spectrum β-lactamase enzyme. Toxic metals such as cadmium, copper, iron, lead and zinc also exert a selection pressure towards antibiotic resistance. Pseudomonas aeruginosa strain GCC_19W3, Bacillus sp. strain GCC_19S2 and Achromobacter spanius strain GCC_SB1 showed β-hemolysis, evidenced by the complete breakdown of the red blood cells. -
P-Glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain and Blood Disposition of the Mtor Inhibitor Everolimus (Afinitor) in Mice
Published OnlineFirst April 11, 2014; DOI: 10.1158/1078-0432.CCR-13-1759 Clinical Cancer Cancer Therapy: Preclinical Research P-Glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain and Blood Disposition of the mTOR Inhibitor Everolimus (Afinitor) in Mice Seng Chuan Tang1, Rolf W. Sparidans3, Ka Lei Cheung4, Tatsuki Fukami5, Selvi Durmus1, Els Wagenaar1, Tsuyoshi Yokoi5, Bart J.M. van Vlijmen4, Jos H. Beijnen2,3, and Alfred H. Schinkel1 Abstract Purpose: To clarify the role of ABCB1, ABCG2, and CYP3A in blood and brain exposure of everolimus using knockout mouse models. À À À À À À À À Experimental Design: We used wild-type, Abcb1a/1b / , Abcg2 / , Abcb1a/1b;Abcg2 / , and Cyp3a / mice to study everolimus oral bioavailability and brain accumulation. Results: Following everolimus administration, brain concentrations and brain-to-liver ratios were À À À À À À substantially increased in Abcb1a/1b / and Abcb1a/1b;Abcg2 / , but not Abcg2 / mice. The fraction of everolimus located in the plasma compartment was highly increased in all knockout strains. In vitro, everolimus was rapidly degraded in wild-type but not knockout plasma. Carboxylesterase 1c (Ces1c), a plasma carboxylesterase gene, was highly upregulated (80-fold) in the liver of knockout mice relative to wild-type mice, and plasma Ces1c likely protected everolimus from degradation by binding and stabilizing it. This binding was prevented by preincubation with the carboxylesterase inhibitor BNPP. In vivo knockdown experiments confirmed the involvement of Ces1c in everolimus stabilization. Everolimus also markedly inhibited the hydrolysis of irinotecan and p-nitrophenyl acetate by mouse plasma carboxylesterase À À and recombinant human CES2, respectively. -
Glycolytic Strategy As a Tradeoff Between Energy Yield and Protein Cost
Glycolytic strategy as a tradeoff between energy SEE COMMENTARY yield and protein cost Avi Flamholza,1, Elad Noora,1, Arren Bar-Evena, Wolfram Liebermeistera,b, and Ron Miloa,2 aDepartment of Plant Sciences, The Weizmann Institute of Science, Rehovot 76100, Israel; and bInstitut für Biochemie, Charité–Universitätsmedizin Berlin, 10117 Berlin, Germany Edited by Richard E. Lenski, Michigan State University, East Lansing, MI, and approved April 4, 2013 (received for review September 17, 2012) Contrary to the textbook portrayal of glycolysis as a single pathway sequence from glyceraldehyde 3-phosphate (G3P) through pyruvate conserved across all domains of life, not all sugar-consuming known as “lower glycolysis.” In the EMP pathway, glucose is organisms use the canonical Embden–Meyerhoff–Parnass (EMP) phosphorylated twice and cleaved into two triose-phosphates glycolytic pathway. Prokaryotic glucose metabolism is particularly (G3P and dihydroxyacetone phosphate), both of which are used to diverse, including several alternative glycolytic pathways, the most produce ATP through substrate-level phosphorylation in lower gly- common of which is the Entner–Doudoroff (ED) pathway. The prev- colysis (2, 7) (Fig. 1B). In the ED pathway, glucose is phosphory- alence of the ED pathway is puzzling as it produces only one ATP lated only once and oxidized to 2-keto-3-deoxy-6-phosphogluconate per glucose—half as much as the EMP pathway. We argue that the (KDPG), which is cleaved into one pyruvate and one G3P. Pyruvate diversity of prokaryotic glucose metabolism may reflect a tradeoff does not support substrate-level phosphorylation (7) and so, in between a pathway’s energy (ATP) yield and the amount of enzy- the ED pathway, only one of the cleavage products (G3P) is used matic protein required to catalyze pathway flux. -
Loofah Sponges As Bio-Carriers in a Pilot-Scale Integrated Fixed-Film Activated Sludge System for Municipal Wastewater Treatment
sustainability Article Loofah Sponges as Bio-Carriers in a Pilot-Scale Integrated Fixed-Film Activated Sludge System for Municipal Wastewater Treatment Huyen T.T. Dang 1 , Cuong V. Dinh 1 , Khai M. Nguyen 2,* , Nga T.H. Tran 2, Thuy T. Pham 2 and Roberto M. Narbaitz 3 1 Faculty of Environmental Engineering, National University of Civil Engineering, No 55, Giai Phong Street, Hanoi 84024, Vietnam; [email protected] (H.T.T.D.); [email protected] (C.V.D.) 2 Faculty of Environmental Sciences, VNU University of Science, 334 Nguyen Trai, Thanh Xuan, Hanoi 84024, Vietnam; [email protected] (N.T.H.T.); [email protected] (T.T.P.) 3 Department of Civil Engineering, University of Ottawa, 161 Louis Pasteur Pvt., Ottawa, ON K1N 6N5, Canada; [email protected] * Correspondence: [email protected] Received: 15 May 2020; Accepted: 5 June 2020; Published: 10 June 2020 Abstract: Fixed-film biofilm reactors are considered one of the most effective wastewater treatment processes, however, the cost of their plastic bio-carriers makes them less attractive for application in developing countries. This study evaluated loofah sponges, an eco-friendly renewable agricultural product, as bio-carriers in a pilot-scale integrated fixed-film activated sludge (IFAS) system for the treatment of municipal wastewater. Tests showed that pristine loofah sponges disintegrated within two weeks resulting in a decrease in the treatment efficiencies. Accordingly, loofah sponges were modified by coating them with CaCO3 and polymer. IFAS pilot tests using the modified loofah sponges achieved 83% organic removal and 71% total nitrogen removal and met Vietnam’s wastewater effluent discharge standards. -
Behavioural, Ecological, and Genetic Determinants of Mating and Gene
Thesis committee Thesis supervisor Prof. dr. Marcel Dicke Professor of Entomology, Wageningen University Thesis co-supervisor Dr. Ir. Bart G.J. Knols Medical Entomologist, University of Amsterdam Other members Prof. dr. B.J. Zwaan, Wageningen University Prof. dr. P. Kager, University of Amsterdam Dr. Ir. P. Bijma, Wageningen University Dr. Ir. I.M.A. Heitkonig, Wageningen University This research was conducted under the auspices of the C. T. de Wit Graduate School for Production Ecology and Resource Conservation Behavioural, ecological and genetic determinants of mating and gene flow in African malaria mosquitoes Kija R.N. Ng’habi Thesis Submitted in fulfillment of the requirement for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. dr. M.J. Kropff, in the presence of the Thesis committee appointed by the Academic Board to be defended in public at on Monday 25 October 2010 at 11:00 a.m. in the Aula. Kija R.N. Ng’habi (2010) Behavioural, ecological and genetic determinants of mating and gene flow in African malaria mosquitoes PhD thesis, Wageningen University – with references – with summaries in Dutch and English ISBN – 978-90-8585-766-2 > Abstract Malaria is still a leading threat to the survival of young children and pregnant women, especially in the African region. The ongoing battle against malaria has been hampered by the emergence of drug and insecticide resistance amongst parasites and vectors, re- spectively. The Sterile Insect Technique (SIT) and genetically modified mosquitoes (GM) are new proposed vector control approaches. Successful implementation of these ap- proaches requires a better understanding of male mating biology of target mosquito species.